This Week in Cardiology

 
 
  • Dec 13, 2019 This Week in Cardiology   The EXCEL trial controversy, and Dr John Mandrola's experience with vernakalant at FDA are the topics covered in this week's podcast.
  • Dec 6, 2019 This Week in Cardiology   Vernakalent, CV death in cancer patients, dapagliflozin, and sacubitril/valsartan are the topics Dr. John Mandrola discusses in this week's podcast.
  • Nov 22 2019 This Week in Cardiology   Highlights from the 2019 AHA meeting are analyzed by Dr John Mandrola in this week’s podcast.
  • Nov 15 2019 This Week in Cardiology   Interruption of oral anticoagulation, marijuana and stroke, ORBITA substudy, ISCHEMIA medical therapy targets, and more on AHA are the topics discussed by Dr. John Mandrola in this week’s podcast.
  • Nov 8 2019 This Week in Cardiology   Words that harm, statins, thyroid replacement, and the ISCHEMIA trial are the topics discussed by Dr John Mandrola in this week’s podcast.
  • Nov 1 2019 This Week in Cardiology   Mortality after AF ablation, cardiac rehab programs, hypertrophic cardiomyopathy, and clinician wellness are the topics Dr. John Mandrola discusses in this week’s podcast.
  • Oct 25 2019 This Week in Cardiology   AF after TAVR, opioids after cardiac devices, hypertension in black adults, and post-cardiac surgery AF are the topics Dr John Mandrola discusses in this week’s podcast.
  • Oct 18 2019 This Week in Cardiology   The Nobel Prize, more on the EXCEL trial, the costs of cardiac tests, familial hypercholesterolemia, and burnout are the topics discussed by Dr John Mandrola in this week’s podcast.
  • Oct 11 2019 This Week in Cardiology   Left main PCI vs CABG trials and TAVR vs SAVR—in this week’s podcast, Dr John Mandrola takes a deeper dive.
  • Sep 27 2019 This Week in Cardiology   Social effects of medicine, SGLT2 inhibitors, CIED infections, equity in cardiology, and post-PCI anti-thrombotic therapy are the topics discussed by Dr John Mandrola in this week’s podcast.
  • Sep 20 2019 This Week in Cardiology   The polypill, dapagliflozin, TAVR, and video games are discussed by John Mandrola, MD, in this week’s podcast.
  • Sep 13 2019 This Week in Cardiology   More from ESC: Antiplatelets and NOACs, blood glucose control, high sensitivity troponin tests, and ICD trials are all covered by John Mandrola, MD, in this week’s podcast.
  • Sep 6 2019 This Week in Cardiology   Six major trials from the ESC meeting in Paris are reviewed by John Mandrola, MD, in this week’s podcast.
  • Aug 30 2019 This Week in Cardiology   Digital health, a new LDL-c lowering drug, PCSK9i outcomes in higher risk patients, and an ESC preview are discussed by John Mandrola in this week’s podcast.
  • Aug 23 2019 This Week in Cardiology   TAVR, baroreflex activation for heart failure, dapagliflozin for HF, and myocardial viability are the topics discussed by John Mandrola in this week’s podcast.
  • Aug 16 2019 This Week in Cardiology   AI for AF detection, syncope and PE, thoracentesis, fish oil, and why doctors should organize are the topics covered by John Mandrola in this week’s podcast.
  • Aug 2 2019 This Week in Cardiology   Digoxin, acupuncture and angina, heart failure with preserved ejection fraction, bariatric surgery, and cardiac device complications are the topics John Mandrola covers in this week's podcast.
  • Jul 26 2019 This Week in Cardiology   CRT in patients with non-LBBB, ezetimibe, lifestyle diseases in the young, end of life care, and diabetes for the cardiologist are the topics John Mandrola, MD discusses in this week’s podcast
  • Jul 19 2019 This Week in Cardiology   Deprescribing beta bockers, interrupting oral anticoagulants, sudden death, quality measures, and acute stroke care are the topics John Mandrola, MD discusses in this week’s podcast.
  • Jul 12 2019 This Week in Cardiology   High-sensitivity troponin assays, nursing education, negative risk markers, valve-in-valve TAVRs, and the use of AI in medical practice are covered in this week’s podcast.